Investigating congenital cytomegalovirus infection in newborns
Official title: NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS (CCMV) INFECTION
Funded at Nysdoh/health Research, INC. · NIH-10937099 · Data updated 2026-11-12
This study is looking at how to better diagnose and care for babies born with congenital cytomegalovirus (cCMV), a common infection that can cause health problems, and it aims to find the best ways to support their growth and development through regular check-ups and telehealth.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nysdoh/health Research, INC. NIH-funded |
| Lab location | 1 site (Menands, United States) |
| Project start | September 28, 2023 |
| Project end | September 27, 2026 |
| Funding year | 2023 |
| Award (this year) | $3,494,712 |
| NIH project number | 75N94021D00018-0-759402300001-1 |
| Project ID | NIH-10937099 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are newborns diagnosed with congenital cytomegalovirus infection, particularly those who are symptomatic or at high risk for developing complications.
✕Less likely to help
Patients who are not newborns or those without a diagnosis of congenital cytomegalovirus infection may not receive any benefit from this research.
What this research studies
This research focuses on congenital cytomegalovirus (cCMV), the most common congenital infection affecting newborns. It aims to improve early diagnosis and follow-up care for infants diagnosed with cCMV, which can lead to serious health issues such as hearing loss and developmental delays. The study will assess the long-term outcomes of both symptomatic and asymptomatic newborns, utilizing telehealth and health assessments to monitor their progress. By identifying effective treatment options, the research seeks to enhance the quality of care for affected infants.
Why it matters
Potential benefit: If successful, this research could lead to improved early diagnosis and treatment options for newborns with cCMV, ultimately enhancing their long-term health outcomes.
How similar studies have gone: Previous research has shown that early diagnosis and treatment of cCMV can improve outcomes, indicating that this approach has potential based on established findings.
Where this research is happening
-
Nysdoh/health Research, INC.
Menands, United States Active
Researchers
- Principal investigator: Caggana, Michele — Nysdoh/health Research, INC.
- Study coordinator: Caggana, Michele
Related research
Other NIH-funded projects on the same topics.
-
Adaptive e-learning and smartphones to improve newborn and child care in Tanzania
A new program uses smart devices and tailored online learning to help frontline health workers in Mwanza, Tanzania provide better care for newborns and young children.
-
NoviGuide for Newborn Care in Pakistan
A small NIH grant to test a pocket-sized decision support tool for nurses and doctors to improve newborn care in Pakistan.
-
Newborn screening: using gene and metabolite data to refine true vs false positives
A study using genetic and metabolomic data from newborn blood spots to better distinguish real metabolic disorders from false alarms.
-
Evidence-based practices for managing neonatal hypothermia in newborn nurseries
A doctor-led project will study how common newborn hypothermia affects babies in US nurseries and develop trusted guidelines to improve care.
-
Agricultural livelihoods to improve health for pregnant women with HIV in Kenya
A pregnancy-starting program in Kenya tests whether helping families grow food and earn income can improve the health and nutrition of mothers and their babies, especially for women living with HIV.
-
Agricultural livelihood support for pregnant women and newborns in Kenya
Compares agricultural livelihood support to usual care to help pregnant women in Kenya—including those living with HIV—have better nutrition and healthier newborns.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.